Overview
- 6 inspections across 6 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-03-27.
At a glance
Inspections
6
Sites
6
Observations
0
Career since
Sep 2024
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Zennova LLC | 27 Mar 2026 | Human Drugs | On file |
| Suzhou Guochen Biotek Co., Ltd | 6 Feb 2026 | Human Drugs | |
| Labcorp Drug Development | 30 Jan 2026 | Human Drugs | |
| Janssen Pharmaceutica, N.V. | 5 Sep 2025 | Human Drugs | On file |
| SGS France Life Sciences | 29 Aug 2025 | Human Drugs | On file |
Sites inspected
Zennova LLCOrangeburg, United States1 insp.
Suzhou Guochen Biotek Co., LtdSuzhou, China1 insp.
Labcorp Drug DevelopmentShanghai, China1 insp.
Janssen Pharmaceutica, N.V.Beerse, Belgium1 insp.
SGS France Life SciencesSaint-Benoit, France1 insp.
Co-investigators
Investigators who share inspections with this person.
Full investigator report
Get the verbatim findings behind Xingfang Li's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site